MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202647123002 A) filed by Althera Laboratories India Pvt. Ltd. on October 14, 2026, for Palatable Icosapent Ethyl Formulation With Statin And Method Thereof.
Inventors include Ray, Dr. Debajyoti; K, Dr. Karthikeyan; P. K, Mr. Shrikanth; Ramani, Dr. Chandir; and Dias, Ms. Charmaine.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The disclosed embodiment relates to a palatable icosapent ethyl formulation with statin. More particularly, the formulation comprises of icosapent ethyl, antioxidant, statin, alkalizer, wetting agent, suspending agent, diluent, flavouring agent, and sweetening agent. Furthermore, the statin is rosuvastatin calcium; the antioxidant is tocopherol; the alkalizer is magnesium oxide; the wetting agent is docusate sodium; the suspending agent is colloidal silicon dioxide; the diluent is miglyol 812; the flavouring agent is peppermint oil; and the sweetening agent is sucralose. The said formulation is an oral suspension for reduction of triglyceride (TG) levels and stabilization of atherosclerotic plaque.
Disclaimer: Curated by HT Syndication.
